Prenatal NSAID Use Significantly Underreported - Study
This article was originally published in The Tan Sheet
Executive Summary
Easy access to nonsteroidal, anti-inflammatory drugs by pregnant women "should be re-evaluated" in light of findings that in utero exposure to aspirin, ibuprofen and naproxen is significantly higher than indicated by maternal history, Michigan researchers say in the March issue of Pediatrics.
You may also be interested in...
NSAIDs, Increased Risk Of Miscarriage Link Suggested In BMJ Study
Use of non-steroidal anti-inflammatory drugs during pregnancy does not appear to increase the risk of adverse birth outcomes but may be associated with an increased risk of miscarriage, Danish researchers report.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands